Ambeed.cn

首页 / Dorsomorphin

Dorsomorphin {[allProObj[0].p_purity_real_show]}

货号:A137399 同义名: Compound C; BML-275

Dorsomorphin 是一种选择性、ATP 竞争性的 AMPK 抑制剂 (在没有 AMP 的情况下,Ki 为 109 nM),选择性抑制 BMP I 型受体 ALK2、ALK3 和 ALK6,并可逆转 Urolithin A导致的自噬激活和抗炎作用。Dorsomorphin可促进人类多能干细胞分化为神经祖细胞,促进小鼠和人类多能干细胞分化为心肌细胞,促进人类间充质细胞的脂肪分化,抑制成骨细胞的分化。

Dorsomorphin 化学结构 CAS号:866405-64-3
Dorsomorphin 化学结构
CAS号:866405-64-3
Dorsomorphin 3D分子结构
CAS号:866405-64-3
Dorsomorphin 化学结构 CAS号:866405-64-3
Dorsomorphin 3D分子结构 CAS号:866405-64-3
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Dorsomorphin 纯度/质量文件 产品仅供科研

货号:A137399 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

Dorsomorphin 生物活性

靶点
  • AMPK

    AMPK, Ki:109 nM

描述 Dorsomorphin, known as compound C, is a reversible selective ATP-competitive inhibitor of AMPK with Ki of 109 nM. Dorsomorphin can also inhibit the bone morphogenic protein (BMP) signaling and do not effect the expression of several structurally related kinases including ZAPK, SYK, PKCq, PKA, and JAK3[3]. In addition, dorsomorphin could stimulate the oxidation of long chain fatty acids independently in adipocytes by increasing carnitine palmitoyltransferase-1 (CPT1) activity[4] and remarkly reduce the adipogenic Differentiation of 3T3-L1 cells at 10 μM[5]. Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway[6]. In vivo, dorsomorphin induces dorsalization in zebrafish embryos and the differentiation of osteoblast[7].

Dorsomorphin 细胞实验

Cell Line
Concentration Treated Time Description References
U937 cells 5 μM 24 h Enhanced cell death induced by navitoclax, S63845, or A-1155463. Cell Death Differ. 2024 Apr;31(4):405-416.
Hep3B cells 10 µM 16 h Dorsomorphin inhibited BMP2- and HJV-induced hepcidin promoter activity. Nat Chem Biol. 2008 Jan;4(1):33-41.
MRC-5 fetal lung fibroblasts 1 μM 4 days Dorsomorphin synergizes with FSK to promote neuronal survival and maturation, although independently DM has no effect on neuronal conversion. Nat Commun. 2013;4:2183.
IMR-90 fetal lung fibroblasts 1 μM 4 days Dorsomorphin synergizes with FSK to promote neuronal survival and maturation, although independently DM has no effect on neuronal conversion. Nat Commun. 2013;4:2183.
Clinical acute leukemia isolates 5 μM 24 h Synergized with navitoclax, venetoclax, A-1155463, or S63845 to enhance cell death. Cell Death Differ. 2024 Apr;31(4):405-416.
Jurkat cells 5 μM 24 h Inhibited navitoclax- or S63845-induced AMPKα autophosphorylation and substrate phosphorylation, enhancing cell death. Cell Death Differ. 2024 Apr;31(4):405-416.
C2C12 cells 4 µM 5 days Dorsomorphin inhibited BMP4- and BMP6-induced alkaline phosphatase activity, indicating inhibition of BMP-induced osteogenic differentiation. Nat Chem Biol. 2008 Jan;4(1):33-41.
Mouse pulmonary artery smooth muscle cells (PASMCs) 0.47 µM 30 min Dorsomorphin inhibited BMP4-induced phosphorylation of BMP-responsive SMADs, without affecting MAPK p38 activation. Nat Chem Biol. 2008 Jan;4(1):33-41.
Zebrafish embryos 0.312 μM or 0.625 μM To investigate the effects of DMP on zebrafish embryonic development, particularly on dorsoventral patterning. Results showed that DMP treatment caused dorsalization of embryos, similar to the phenotype induced by TDCIPP. Environ Sci Technol. 2018 Sep 18;52(18):10820-10828.
Saos2 cells 5 μM 24 h To investigate the effect of Dorsomorphin on the migration and invasion of Saos2 cells, results showed that Dorsomorphin significantly inhibited the migration and invasion induced by TMEM119 overexpression. Exp Mol Med. 2017 May 12;49(5):e329.
FOP fibroblasts 1 μM 25 days Inhibited BMP-SMAD signaling, significantly reducing iPSC generation from FOP fibroblasts Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13057-13062.
WT-hepatocytes 10 µM 9 h Dorsomorphin completely restored the A23187-mediated inhibition of glycogen deposition, suggesting that the inhibitory effects of A23187 are mediated by AMPK signaling. Mol Metab. 2024 Jun;84:101942.
WT-hepatocytes 1, 3, or 10 µM 9 h Dorsomorphin reversed the ethanol-mediated inhibition of glycogen levels, indicating that ethanol suppresses glycogen deposition through the AMPK signaling pathway. Mol Metab. 2024 Jun;84:101942.
3T3-L1 fibroblasts 1 μmol/mL 24 h To verify whether AMPK mediates the anti-fibrotic effect of ORM, results showed that dorsomorphin reversed the inhibitory effect of ORM on fibrotic markers Acta Pharmacol Sin. 2022 Feb;43(2):367-375.

Dorsomorphin 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c Nude mice Jurkat, U937, or MV-4-11 xenograft models Intraperitoneal injection 25 mg/kg Three times a week for two weeks The combination of dorsomorphin with navitoclax or S63845 significantly inhibited xenograft growth with minimal toxicity to normal tissues. Cell Death Differ. 2024 Apr;31(4):405-416.
Zebrafish Adult zebrafish Intraperitoneal injection 23 µg/g Single injection Dorsomorphin inhibited iron-induced hepatic SMAD1/5/8 phosphorylation and hepcidin expression. Nat Chem Biol. 2008 Jan;4(1):33-41.
Zebrafish Zebrafish embryos Exposure in embryo media 0.312 μM or 0.625 μM Exposure initiated at 0.75 hpf To investigate the effects of DMP on zebrafish embryonic development, particularly on dorsoventral patterning. Results showed that DMP treatment caused dorsalization of embryos, similar to the phenotype induced by TDCIPP. Environ Sci Technol. 2018 Sep 18;52(18):10820-10828.
Rats Streptozotocin-induced diabetic peripheral neuropathy model Intraperitoneal injection 0.2 mg/kg Once daily for 15 days To investigate the effect of Dorsomorphin on the protective role of Empagliflozin in diabetic peripheral neuropathy, results showed that Dorsomorphin almost completely abolished the beneficial effects of Empagliflozin. Arch Pharm Res. 2022 Jul;45(7):475-493

Dorsomorphin 动物研究

Dose Mice: 3 mg/kg - 12 mg/kg[3] (i.p.) Rat: 0.2 mg/kg[4] (i.v.)
Administration i.p., i.v.

Dorsomorphin 参考文献

[1](6):100-6. Russian.

[2]281(36):25956-64.

[3]Kutiakov MG. Rezul'taty rezektsii zheludka po povodu iazvennoĭ bolezni [Results of stomach resection for peptic ulcer]. Khirurgiia (Mosk). 1975 Jun;(6):100-6. Russian.

[4]Gaidhu MP, Fediuc S, Ceddia RB. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes. J Biol Chem. 2006 Sep 8;281(36):25956-64.

[5]Gao Y, Zhou Y, Xu A, Wu D. Effects of an AMP-activated protein kinase inhibitor, compound C, on adipogenic differentiation of 3T3-L1 cells. Biol Pharm Bull. 2008 Sep;31(9):1716-22.

Dorsomorphin 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.50mL

0.50mL

0.25mL

12.52mL

2.50mL

1.25mL

25.03mL

5.01mL

2.50mL

Dorsomorphin 技术信息

CAS号866405-64-3
分子式C24H25N5O
分子量 399.49
SMILES Code C(CN1CCCCC1)OC1=CC=C(C=C1)C1=CN2N=CC(=C2N=C1)C1=CC=NC=C1
MDL No. MFCD08705402
别名 Compound C; BML-275
运输蓝冰
InChI Key XHBVYDAKJHETMP-UHFFFAOYSA-N
Pubchem ID 11524144
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Keep in dark place,Inert atmosphere,2-8°C

溶解方案

DMSO: 35 mg/mL(87.61 mM),配合低频超声,并调节pH至2,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

1M HCl: 50 mg/mL(125.16 mM),配合低频超声,并调节pH至1

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。